Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, MD
Citation: Ne. Austin et al., Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor, BIOORG MED, 11(5), 2001, pp. 685-688
Authors:
Austin, NE
Baldwin, SJ
Cutler, L
Deeks, N
Kelly, PJ
Nash, M
Shardlow, CE
Stemp, G
Thewlis, K
Ayrton, A
Jeffrey, P
Citation: Ne. Austin et al., Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase, XENOBIOTICA, 31(8-9), 2001, pp. 677-686
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, M
Citation: Ne. Austin et al., Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 10(22), 2000, pp. 2553-2555
Authors:
Blades, K
Donohoe, TJ
Winter, JJG
Stemp, G
Citation: K. Blades et al., A syn selective dihydroxylation of cyclic allylic trichloroacetamides using catalytic osmium tetroxide, TETRAHEDR L, 41(24), 2000, pp. 4701-4704
Authors:
Reavill, C
Taylor, SG
Wood, MD
Ashmeade, T
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Cilia, J
Coldwell, MC
Hadley, MS
Hunter, AJ
Jeffrey, P
Jewitt, F
Johnson, CN
Jones, DNC
Medhurst, AD
Middlemiss, DN
Nash, DJ
Riley, GJ
Routledge, C
Stemp, G
Thewlis, KM
Trail, B
Vong, AKK
Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Authors:
Ashby, CR
Minabe, Y
Stemp, G
Hagan, JJ
Middlemiss, DN
Citation: Cr. Ashby et al., Acute and chronic administration of the selective D-3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study, J PHARM EXP, 294(3), 2000, pp. 1166-1174
Authors:
Stemp, G
Ashmeade, T
Branch, CL
Hadley, MS
Hunter, AJ
Johnson, CN
Nash, DJ
Thewlis, KM
Vong, AKK
Austin, NE
Jeffrey, P
Avenell, KY
Boyfield, I
Hagan, JJ
Middlemiss, DN
Reavill, C
Riley, GJ
Routledge, C
Wood, M
Citation: G. Stemp et al., Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J MED CHEM, 43(9), 2000, pp. 1878-1885
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Coldwell, MC
Hadley, MS
Jeffrey, P
Johns, A
Johnson, CN
Nash, DJ
Riley, GJ
Smith, SA
Stacey, RC
Stemp, G
Thewlis, KM
Vong, AKK
Citation: Ne. Austin et al., Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(2), 1999, pp. 179-184
Authors:
Avenell, KY
Boyfield, I
Hadley, MS
Johnson, CN
Nash, DJ
Riley, GJ
Stemp, G
Citation: Ky. Avenell et al., Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(18), 1999, pp. 2715-2720
Authors:
Coldwell, MC
Boyfield, I
Brown, AM
Stemp, G
Middlemiss, DN
Citation: Mc. Coldwell et al., Pharmacological characterization of extracellular acidification rate responses in human D-2(long), D-3 and D-4.4 receptors expressed in Chinese hamster ovary cells, BR J PHARM, 127(5), 1999, pp. 1135-1144